A law signed in 2023 caps out-of-pocket costs for insulin, asthma inhalers, and epinephrine injectors beginning Jan. 1.

Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first ...

Amneal beats Teva’s challenge of ruling on some ProAir patents Decision could impact other ‘junk device listings,’ FTC says Five patents related to Teva Pharmaceutical Industries Ltd.’s ProAir HFA ...

A newer category of treatments, biologics are medications that help control asthma and other allergic conditions if you don’t respond to typical therapies like inhalers or oral medications. Biologics, ...

Dear Dr. Roach: It seems that many of the medications I see advertised on television carry a warning about “thoughts of suicide.” Can you explain why so many diverse drugs share this same side ...

And as up to 90% of inhaler users do not use their inhalers correctly ... son master the technique and he was then able to take his medication properly and miraculously without distress.

From 2017 to 2020, it increased to 41.9%. Prescription weight loss medication has become extremely popular because it is easy to take and effective. But, it is expensive, and people must also try ...

A major review of evidence on ADHD treatment in adults has found stimulant drugs and one type of non-stimulant are the only effective treatments for reducing core symptoms of the condition.

In addition to obesity-related conditions, some patients are being prescribed the drugs to lose weight and become eligible for services, including organ transplants, fertility treatments or knee ...

As Mark Moran was facing another 90-hour week as an investment-banking intern at Credit Suisse in New York, he knew he needed help to survive the rest of the summer. His colleagues gave him a tip ...

U.S. Adult Obesity Rate Fell in 2023, as Use of GLP-1 Meds Rose By Ernie Mundell HealthDay Reporter FRIDAY, Dec. 13, 2024 (HealthDay News) -- The U.S. obesity rate declined for the first time in a ...

The U.S. obesity rate declined for the first time in a decade last year, coinciding with the rise of GLP-1 weight-loss meds, a new study finds. Data on almost 17 million adults nationwide showed ...